Stocks · Health care · Pharmaceutical Preparations

Verastem, Inc.

VSTM Clue Score56

United States Fiscal year ends December CIK 0001526119 Results filed 14 Oct 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

13 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Dan Paterson

President and CEO

—

$12.47K (1) scheduled

−$12.47K

651,413

0.7193%

$6.25M

−18.1%

Brian M Stuglik

Director

—

—

—

137,147

0.1514%

$1.32M

+42.7%

Daniel Calkins

Chief Financial Officer

—

—

—

123,781

0.1367%

$1.19M

−13.4%

Michael P Bailey

Director

—

—

—

108,000

0.1193%

$1.04M

—

Eric K Rowinsky

Director

—

—

—

52,666

0.0582%

$505.59K

+532.0%

Anil Kapur

Director

—

—

—

52,666

0.0582%

$505.59K

+532.0%

John Johnson

Director

—

—

—

52,666

0.0582%

$505.59K

+532.0%

Michelle Robertson

Director

—

—

—

52,666

0.0582%

$505.59K

+532.0%

Karin Anna Tollefson

Director

—

—

—

52,666

0.0582%

$505.59K

+532.0%

Matthew Ros

Chief Operating Officer

—

—

—

50,000

0.0552%

$480.00K

—

Paul A. Bunn

Director

—

—

—

44,333

0.0490%

$425.60K

+432.0%

Robert E. Gagnon

Director

—

—

—

41,678

0.0460%

$400.11K

+19.4%

Michael Kauffman

President of Development

—

—

—

8,666

0.0096%

$83.19K

−2.4%